BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 23744794)

  • 1. Association between statin adherence and cholesterol level reduction from baseline in a veteran population.
    Kazerooni R; Watanabe JH; Bounthavong M
    Pharmacotherapy; 2013 Oct; 33(10):1044-52. PubMed ID: 23744794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of copayment and statin adherence stratified by socioeconomic status.
    Kazerooni R; Bounthavong M; Watanabe JH
    Ann Pharmacother; 2013 Nov; 47(11):1463-70. PubMed ID: 24259605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting the medication possession ratio threshold for adherence in lipid management.
    Watanabe JH; Bounthavong M; Chen T
    Curr Med Res Opin; 2013 Mar; 29(3):175-80. PubMed ID: 23320610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between persistence with statin therapy and reduction in low-density lipoprotein cholesterol level: analysis of real-life data from community settings.
    Shalev V; Goldshtein I; Halpern Y; Chodick G
    Pharmacotherapy; 2014 Jan; 34(1):1-8. PubMed ID: 23836549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
    Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of copayment and socioeconomic status with hormonal contraceptive adherence in a female veteran population.
    Kazerooni R; Vu K; Takizawa A; Broadhead C; Morreale AP
    Womens Health Issues; 2014; 24(2):e237-41. PubMed ID: 24533983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-high-density lipoprotein cholesterol reporting and goal attainment in primary care.
    Virani SS; Wang D; Woodard LD; Chitwood SS; Landrum CR; Zieve FJ; Ballantyne CM; Petersen LA
    J Clin Lipidol; 2012; 6(6):545-52. PubMed ID: 23312050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of polypharmacy and statin new-user adherence in a Veterans Health Administration population: a retrospective cohort study.
    Watanabe JH; Bounthavong M; Chen T; Ney JP
    Ann Pharmacother; 2013 Oct; 47(10):1253-9. PubMed ID: 24259688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low high-density lipoprotein cholesterol is not a risk factor for recurrent vascular events in patients with vascular disease on intensive lipid-lowering medication.
    van de Woestijne AP; van der Graaf Y; Liem AH; Cramer MJ; Westerink J; Visseren FL;
    J Am Coll Cardiol; 2013 Nov; 62(20):1834-41. PubMed ID: 23948286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between achieving low-density lipoprotein cholesterol (LDL-C) goal and statin treatment in an employee population.
    Burton WN; Chen CY; Schultz AB; Edington DW
    Popul Health Manag; 2010 Feb; 13(1):1-8. PubMed ID: 20158317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).
    Ballantyne CM; Pitt B; Loscalzo J; Cain VA; Raichlen JS
    Am J Cardiol; 2013 Feb; 111(4):506-9. PubMed ID: 23237107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to statins and LDL-cholesterol goal attainment.
    Chi MD; Vansomphone SS; Liu IL; Cheetham C; Green KR; Scott RD; Reynolds K
    Am J Manag Care; 2014 Apr; 20(4):e105-12. PubMed ID: 24884955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.
    Bullano MF; Wertz DA; Yang GW; Kamat S; Borok GM; Gandhi S; McDonough KL; Willey VJ
    Pharmacotherapy; 2006 Apr; 26(4):469-78. PubMed ID: 16553504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
    Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
    JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of statin medications on prostate-specific antigen levels.
    Hamilton RJ; Goldberg KC; Platz EA; Freedland SJ
    J Natl Cancer Inst; 2008 Nov; 100(21):1511-8. PubMed ID: 18957682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can group medical clinics improve lipid management in diabetes?
    Crowley MJ; Melnyk SD; Ostroff JL; Fredrickson SK; Jeffreys AS; Coffman CJ; Edelman D
    Am J Med; 2014 Feb; 127(2):145-51. PubMed ID: 24462012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.